Претрага
Резултати
New transcriptional regulatory element within the intron of phenylalanine hydroxylase gene [2009]
Stojiljković, MajaDecreased plasma L-arginine levels in organic acidurias (MMA and PA) and decreased plasma branched-chain amino acid levels in urea cycle disorders as a potential cause of growth retardation: Options for treatment
[2019]
Molema, Femke; ...; Đorđević, Maja S. Significant, continuous improvement in Bone Mineral Density (BMD) among type 1 Gaucher disease patients treated with Velaglucerase Alfa: 69-month experience, including dose reduction [2011]
Elstein, Deborah; Foldes, Joseph A; Zahrieh, David; Cohn, Gabriel M; Djordjevic, Maja S; Brutaru, Costin; Zimran, AnLong Term Safety and Efficacy Data of Taliglucerase Alfa, a Plant Cell Expressed Recombinant Glucocerebrosidase, in Treatment Of Naive Gaucher Disease Patients [2012]
Zimran, Ari; Heitner, Rene; Mehta, Atul; Giraldo, Pllar; Rosenbaum, Hanna; Giona, Florina; Amato, Dominick J; Petakov, Milan S; Meillon, Garcia Luis Antonio; Solorio, Meza Sergio Eduardo;
Duran, Gloria; Elstein, Deborah; Brill-Almon, Einat;
Novel transcriptional regulatory element in the phenylalanine hydroxylase gene intron 8 [2010]
Stojiljković, MajaLong-term safety and efficacy data of taliglucerase alfa, a Plant cell-expressed recombinant glucocerebrosidase, in the treatment of naive Gaucher disease patients: 36-Month Results [2013]
Zimran, Ari; Mehta, Atul; Giraldo, Pilar; Rosenbaum, Hanna; Giona, Fiorina; Amato, Dominick J; Petakov, Milan S; Terreros, Munoz Eduardo; Eduardo, Solorio-Meza Sergio; Duran, Gloria;
Elstein, Deborah; Chertkoff, Raul; Brill-Almon, Einat;
Long Term Bone Marrow Responses, as Measured by Quantitative Chemical Shift Imaging (QCSI) MRI, Following Treatment With Taliglucerase Alfa in Patients with Type 1 Gaucher Disease [2012]
van, Dussen Laura; Hollak, Carla EM; Zimran, Ari; Petakov, Milan S; Rosenbaum, Hanna; Aviezer, David; Brill-Almon, Einat; Chertkoff, Raul; Maas, MarioLong-term efficacy and safety results of taliglucerase alfa through 5 years in adult treatment-naive patients with Gaucher disease [2016]
Chertkoff, Raul; Zimran, Ari; Duran, Gloria; Giraldo, Pilar; Rosenbaum, Hanna; Giona, Fiorina; Petakov, Milan S; Eduardo, Solorio-Meza Sergio; Cooper, Peter A; Varughese, Sheeba;
Alon, Sari; Brill-Almon, Einat;
Long-term results of ENGAGE: a phase 3, randomized, double blind, placebo-controlled, multi center study investigating the efficacy and safety of eliglustat in adults with type 1 Gaucher disease [2017]
Mistry, Pramod K; ...; Petakov, Milan S; ...; (broj, koautora 18)The genotypic and phenotypic spectrum of MTO1 deficiency [2018]
O'Byrne, James J; Tarailo-Graovac, Maja; ...; (broj, koautora 33)Filteri
Po tipu
- 21